Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders | MicrobiomeTrials← Back to trialsNCT00544115
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2001-10-16Est. Completion: 2007-03-13
Enrollment target: 260 participants Other microbiome trials you might be interested in
Disease/Condition Name Cancer-related Cognitive DysfunctionChronic Lymphocytic Leukemia (CLL)Chronic Myeloid Leukemia, BCR-ABL1 Positive
This study examines whether there are differences in brain health or well-being in patients receiving TKI therapy for le…
Rochester, United StatesEst. completion Feb 28, 2029
Malignancy, HematologicNeoplasms, HematologicNeoplasms, HematopoieticBlood CancerHematological NeoplasmsHematopoietic Malignancies
Dysmyelopoietic Syndromes
Hematopoetic Myelodysplasia
Myeloid Leukemia, Acute
Nonlymphoblastic Leukemia, Acute
Leukemia, Lymphocytic, Acute
Background:
Blood cancers (such as leukemias) can be hard to treat, especially if they have mutations in the TP53 or RA…
Bethesda, United StatesEst. completion Apr 30, 2029
Chronic Myelogenous LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive
This is a long term safety study for patients who have completed a Novartis sponsored asciminib study and are judged by …
Ann Arbor, United StatesEst. completion Aug 30, 2030